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Pentameric ligand-gated ion channels (pLGICs) are
similar in structure but either inhibited or potentiated
by alcohols and anesthetics. This dual modulation
has previously not been understood, but the determi-
nation of X-ray structures of prokaryotic GLIC pro-
vides an ideal model system. Here, we show that a
single-site mutation at the F140 site in the GLIC trans-
membrane domain turns desflurane and chloroform
from inhibitors to potentiators, and that this is
explained by competing allosteric sites. The F140A
mutation opens an intersubunit site lined by N239
(150), I240 (160), and Y263. Free energy calculations
confirm this site is the preferred binding location for
desflurane and chloroform in GLIC F140A. In contrast,
both anesthetics prefer an intrasubunit site in wild-
type GLIC. Modulation is therefore the net effect of
competitive binding between the intersubunit poten-
tiating site and an intrasubunit inhibitory site. This
provides direct evidence for a dual-site model of allo-
steric regulation of pLGICs.
INTRODUCTION
Despite their widespread use in surgery for more than 150 years,
the molecular action of volatile anesthetics is poorly understood.
Early theories of nonspecific action on cell membranes have
given way to evidence for direct modulation of membrane pro-
teins, including the family of pentameric ligand-gated ion chan-
nels (pLGICs; Miller, 2002; Urban and Bleckwenn, 2002). In
this family, pharmacologically relevant concentrations of vola-
tile anesthetics potentiate function of most GABAA receptors
(GABAARs) and glycine receptors (GlyRs), while they inhibit
most nicotinic acetylcholine receptors (nAChRs; Forman and
Miller, 2011). The sites of action of volatile anesthetics on pLGICs
are usually allosteric; they are believed to be distal to the site(s) of
agonist binding, and for most channels it is not possible for theStructure 21, 1307allosteric ligand to open the channel without the agonist present
(Cascio, 2006). This remarkable diversity in the action of allo-
steric ligands in a single family of receptors is different. It pro-
vides an interesting opportunity to better understand membrane
protein conformational changes and allosteric modulation in
general, as well as mechanisms of action for how volatile anes-
thetics and alcohol perturb the function of ligand-gated ion chan-
nels in particular. For a recent review, see Corringer et al., 2012.
Because there are still no X-ray structures available for the
GABAARs and GlyRs, and only a lower-resolution cryo-electron
microscopy structure exists for the nAChR (Unwin, 2005),
some of the historically most important studies of pLGICs have
used site-directed mutagenesis combined with photolabeling
or electrophysiology to experimentally characterize the modula-
tion sites for alcohols and anesthetics. Early photolabeling
studies (Pedersen and Cohen, 1990) proposed a binding site
between subunits for nAChRs, and more recent work has shown
that the modulation of nAChR is influenced by a diverse range of
binding sites, including a site in the extracellular domain (Ziebell
et al., 2004) and two sites in the channel (Chiara et al., 2009; Pan-
dhare et al., 2012) for charged ligands, while uncharged ligands
might bind between subunits close to the extracellular end of the
M2 helix (Arevalo et al., 2005; Chiara et al., 2003). Time-resolved
photolabeling studies have further identified state-dependent
binding sites in the transmembrane (TM) domain and shown
that agonist-driven channel opening can enhance anesthetic
binding to a hydrophobic binding site, which could point to a
selected fit model (Arevalo et al., 2005). There is also evidence
for slow and fast desensitization of the channels being linked
to separate conformational changes in two different cavities
(Yamodo et al., 2010). Some of the first evidence for specific
action sites of alcohol and volatile anesthetics on heteromeric
GABA was provided by Mihic and colleagues (Mihic et al.,
1997), using chimeric receptor constructs with a1/b2 subunits
to identify a1S270/b2N265 (15
0 M2) and a1A291/b2M286 as crit-
ical for modulation. Photolabeling studies on GABA with etomi-
date analogs (Chiara et al., 2012; Li et al., 2006) have identified
intersubunit binding of etomidate close to a1S270/b2N265
(M2 150), and early simulations of homology models of GlyR
could keep ethanol stable in an intersubunit site formed by
S267, A288, and I229 (Cheng et al., 2008). However, other–1316, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1307
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extracellular end of the M3 segment in GABA, and, at least for
GlyR, there are functional mutation studies indicating indepen-
dent contributions of S267 (M2 150) and A52 in the extracellular
domain loop 2 (Brejc et al., 2001), which suggests there might
be multiple potentiating binding sites (Crawford et al., 2007;
Mascia et al., 2000; Perkins et al., 2010).
Because no high-resolution structure has yet been determined
for a human pLGIC, substantial insight has emerged from the
structures of closely related prokaryotic proteins such as the
Gloeobacter violaceus ligand-gated ion channel (GLIC; Bocquet
et al., 2009; Hilf et al., 2010). This bacterial homolog shares 20%
amino acid identity with the human a7 nAChR (Bocquet et al.,
2007) and exhibits inhibition by volatile anesthetics, similar to
nAChRs (Weng et al., 2010). GLIC has been an important tem-
plate for homology models of human receptors, and in previous
work, we have reported microsecond simulations of GlyR where
ethanol spontaneously diffuses to and binds in an intersubunit
location (Murail et al., 2011). This would appear to be contra-
dicted by GLIC co-crystals with the anesthetics desflurane and
propofol located in an intrasubunit site (Nury et al., 2011), but
the recent structure of the eukaryotic GluCl channel by Hibbs
and colleagues has the ligand ivermectin bound between sub-
units (Hibbs and Gouaux, 2011) in close contact with S260 (M2
150), A261, and G262. Superficially, all these data on different
receptors might seem incompatible, although another option is
the existence of multiple different binding sites for alcohols
and/or anesthetics (Bali and Akabas, 2004; Ernst et al., 2005;
Jansen and Akabas, 2006; Trudell and Bertaccini, 2004).
While the GLIC X-ray structures (Nury et al., 2011) point to
an intrasubunit binding site, this prokaryotic channel is mostly
inhibited by volatile anesthetics such as desflurane, propofol, or
chloroform, as well as long chain n-alcohols in contrast to many
of its eukaryotic homologs. This resultmakes it harder to say any-
thing specific about the potentiating allosteric site and mecha-
nism of pLGICs in general. However, recent mutagenesis studies
of GLIC have opened new possibilities to use this channel as
a model system for allosteric potentiation. Replacing the TM
domain of GLIC by the a1 subunit fromGlyR reversesmodulation
of GLIC by anesthetics and long-chain alcohols from inhibitory to
potentiating (Duret et al., 2011), supporting this domain’s role in
mediating inhibition and potentiation. In fact, alcohols as large
as n-hexanol can be converted from inhibitors to potentiators
through a single point mutation, F238A, in the second TM helix
(M2) of GLIC (Howard et al., 2011a). This mutation converts
GLIC into a highly ethanol-sensitive channel comparable to its
eukaryotic relatives GlyRs and GABA. Molecular dynamics
(MD) simulations indicated this is caused by the opening of a
cavity at the intersubunit interface thatmaymediate potentiation,
without substantially altering the intrasubunit binding cavity
observed in X-ray structures. We believe these changes cannot
be explained from a single anesthetic or alcohol-binding site in
pLGICs, no matter what the location is, but that it requires a
dual action mechanism for channel inhibition and potentiation.
Indeed, microsecond simulations of GLIC F238A in the presence
of ethanol show enhanced intersubunit density of ethanol (Murail
et al., 2012), which would correlate well with the proposed bind-
ing sites for anesthetics and alcohols in eukaryotic channels (Ber-
taccini et al., 2005; Cheng et al., 2008; Forman and Miller, 2011).1308 Structure 21, 1307–1316, August 6, 2013 ª2013 Elsevier Ltd AlRecent efforts to simulate anesthetic binding to GLIC using
MD (Brannigan et al., 2010) or combined modeling and trypto-
phan quenching (Chen et al., 2010) have suggested binding to
both intrasubunit and intersubunit sites, as well as sites in the
pore and in loop regions of TM domains. One approach to distin-
guish between such promiscuous possibilities is to calculate the
free energies of binding of a computationally docked compound
in various putative binding sites (Foloppe andHubbard, 2006), an
approach that is becoming increasingly accessible tomembrane
protein studies (LeBard et al., 2012; Lindahl and Sansom, 2008).
In particular, quantitative data on the contributions of specific
sites to anesthetic binding can be compared directly to experi-
ments to connect functional and molecular-level data and criti-
cally test different models for modulation.
In this study, we provide evidence for a dual-site allosteric
modulation effect on ligand-gated ion channels, where the intra-
subunit site is inhibitory and the intersubunit site potentiating.
This has been achieved by combining electrophysiology with
MD simulations to probe how the F238A mutation changes the
modulation response of GLIC to volatile anesthetics. The sin-
gle-site mutation not only shifts, but also completely reverses
the modulation effect in experiments and causes GLIC to be
potentiated rather than inhibited by desflurane and chloroform.
By using docking to a range of putative sites as well as free
energy calculations, we show this is explained by the presence
of two binding sites, where the intrasubunit site has the best
affinity for both compounds in wild-type (WT) GLIC, but in the
F238A mutant, the affinity is swapped with the anesthetics
preferring intersubunit binding. This provides direct support for
an action model where desflurane and chloroform primarily
bind intrasubunit in WT GLIC and inhibit the channel, while the
F238A mutant has a potentiating binding site between subunits.
RESULTS
GLIC WT and F238A Channels Are Differentially
Modulated by Volatile Anesthetics
Whereas GLIC exhibits inhibition by long-chain alcohols such as
n-hexanol, the single-site mutant F238A exhibits potentiation by
the same agents (Howard et al., 2011a). Given past evidence that
alcohols and volatile anesthetics may act via shared binding
sites on pLGICs (Mascia et al., 2000), we investigated the mod-
ulation of GLIC by a variety of volatile anesthetics. We measured
anesthetic modulation by two-electrode voltage clamp electro-
physiology in Xenopus laevis oocytes of GLIC currents at 10%
maximal proton activation, using a similar protocol to that previ-
ously described for n-alcohols (Howard et al., 2011a). Pharma-
cologically relevant doses of volatile anesthetics are generally
described by the minimum alveolar concentration (MAC)
required to eliminate response to a noxious stimulus in 50% of
subjects (Sonner et al., 2003). The volatile agents desflurane,
chloroform, enflurane, and isoflurane inhibited the function of
WT GLIC at or below three times MAC (Weng et al., 2010), while
they potentiated the function of GLIC mutant F238A (Figure 1A).
To quantify the differential modulation of GLIC WT and F238A
channels, we measured modulation at a range of concentrations
of desflurane, an inhalational agent commonly used for general
anesthesia (Meyer, 2010) that was recently co-crystallized in a
TM intrasubunit site of GLIC (Nury et al., 2011). WT GLIC wasl rights reserved
Figure 2. GLIC F238A TM Cavities
(A and B) Illustration of the intrasubunit (red) and intersubunit (blue) cavities
after equilibration of GLIC F238A, shown from the extracellular side (A) and in
the membrane plane (B). The five subunits are rendered in slightly different
colors to depict the cavity locations. Cavities were calculated and illustrated
using the Surfnet module (Laskowski, 1995) in the Chimera program (Pettersen
et al., 2004).
Figure 1. Enhancement of GLIC Potentiation in the F238A Mutant
(A) Modulation of GLIC WT (black) and F238A (orange) channels by volatile
anesthetics: 1.00 mM chloroform, 2.64 mM desflurane, 1.68 mM enflurane,
and 0.90 mM isoflurane (significance versus WT, unpaired t test, *p < 0.05;
**p < 0.01; ***p < 0.001.) The vertical axis is broken to display both WT and
mutant responses clearly. Error bars are SEM; n = 3–10.
(B) Concentration-dependent modulation of GLIC WT (black, lower panel) and
F238A (orange, upper panel) channels by desflurane. Black curve represents
nonlinear regression fit of WT data; orange lines connect F238A mutant data
points, which were poorly fit by regression analysis. Positive and negative
vertical axes are scaled independently to display WT and mutant responses
clearly. Error bars are SEM; n = 3–14.
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with a half-maximal concentration (IC50) of 1.1 mM, 1.3 MAC
(LogIC50 2.9 ± 0.087), and a Hill coefficient less than 1 (0.74 ±
0.19; Figure 1B, black). Conversely, GLIC F238A exhibited little
or no modulation up to 1 MAC desflurane, but was enhanced
more than 4-fold by higher concentrations (Figure 1B, orange).
GLIC potentiation did not appear to saturate at the highest
concentration tolerated by oocytes.
Structural Details of Intrasubunit and Intersubunit
Binding
To identify the binding differences betweenGLICWT and F238A,
we needed to find the best binding poses in the intersubunit and
intrasubunit cavities (Figure 2). We applied ligand docking toStructure 21, 1307obtain initial binding sites followed by 20 ns unrestrained MD
to identify multiple kinetically distinct binding poses. These
poses were used to obtain binding affinities of both anesthetics
in the two sites site of WT and F238A GLIC. The binding free
energy was calculated independently for each pose, and
an occupancy-weighted average calculated in each site. To
increase sampling in the simulations, desflurane or chloroform
ligandswere placed in identical poses in each of the subunit sites–1316, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1309
Figure 3. Desflurane and Chloroform Poses
in the Intrasubunit Cavity of GLIC
(A) Left, desflurane in the intrasubunit binding site,
viewed from the extracellular side. For clarity, only
the TM helices M1–M4 of the proximal subunit
(light gray) and M2–M3 the distal subunit (dark
gray) are shown. Residue F238 (spheres) and
helices contributing to the intrasubunit cavity are
labeled. Right, equivalent view from the extracel-
lular side and a second kinetically distinct pose.
(B) Desflurane binding in WT viewed in the plane of
the membrane in the pore, with F238 marked.
(C andD) Other important residues surrounding the
binding site after equilibration (C), and residue
environment with chloroform (CHL) bound (D).
(E–H) Equivalent binding conformations in the
F238A mutant, with residue F238A marked. Over-
all, the intrasubunit binding was largely unaffected
by the mutation.
See also Figures S1, S2, and Table S1.
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Ion Channel Modulation(Figure 2), although this is not strictly required for modulation in
experiments (Mowrey et al., 2013).
Intrasubunit Binding Conformations
Desflurane was docked into GLIC WT and F238A by using the
cavity from the experimentally identified binding site (Nury
et al., 2011). Neither root-mean-square deviation (rmsd) calcula-1310 Structure 21, 1307–1316, August 6, 2013 ª2013 Elsevier Ltd All rights reservedtion nor manual inspection indicated any
significant differences in the set of binding
poses between the two structures (Fig-
ure S1 available online), which is reason-
able because themutation did not directly
affect this site. The interaction site of des-
flurane in the docking-derived intrasubu-
nit site was made up by I201, I202, and
S205 (I206) of helix M1, V242 of M2, and
T255, Y254, and I258 (I259) of M3, which
is identical to the interacting residues
observed in the X-ray co-crystal reported
earlier (Nury et al., 2011).
Representative conformations of des-
flurane obtained by clustering of snap-
shots along the trajectories, as well as
visual inspection of the trajectories, indi-
cated two poses (Figure 3A). The con-
formational diversity and relatively high
mobility of desflurane in the intrasub-
unit cavity (root-mean-square fluctuation
[rmsf] of 3.55 A˚ in WT and 2.96 A˚ in
F238A) makes it difficult to compare
with a limited-resolution electron density.
However, we found the representative
conformation of one cluster to be within
0.6 A˚ rmsd of the crystal structure (Nury
et al., 2011), which indicates some agree-
ment between simulations and crys-
tallographic data. The crystal structure
points toward hydrogen bond formationbetweenT255and theoxygenatomofdesflurane.However,while
analysis of the trajectories shows that themere distance between
the oxygen of desflurane and the hydroxyl group of T255might be
compatible with hydrogen bonding, the geometric constraints for
hydrogen bond formation are rarely fulfilled either in WT GLIC or
the F238A mutant. The large mobility of desflurane suggests its
binding in the intrasubunit site might not be due specifically to
Figure 4. Desflurane and Chloroform Poses
in the Intersubunit Cavity of GLIC
(A) Left, GLIC structure with desflurane in the in-
tersubunit binding site, viewed from the extracel-
lular side. For clarity, only M1–M4 of the upper
subunit (light gray) and M2–M3 from the lower
subunit (dark gray) are shown. F238 and helices
contributing to the intrasubunit cavity are labeled.
Right, forcing the ligand to bind in the WT close to
F238 either induces a kink inM2 or requires F238 to
adopt a different rotamer.
(B) Desflurane binding viewed in the plane of the
membrane in the pore.
(C) Intersubunit environment for desflurane binding
in WT GLIC; note the proximity to F238.
(D) Chloroform bound to the intersubunit site of WT
GLIC.
(E–H) Corresponding illustrations for ligands bound
to GLIC F238A. The mutation yields a much larger
cavity for ligand binding between the subunits. In
particular, in (G) and (H), desflurane and chloroform
assume poses that would directly overlap with the
F238 side chain.
See also Figures S1, S2, and Table S1.
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Ion Channel Modulationan h-bond between T255 and desflurane, but nonpolar interac-
tions with I202 and S205 and possibly polar interaction between
desfluraneandT255 (Figures3Cand3G)becauseT255A reduces
inhibition (Nury et al., 2011). No differences in these local inter-
actions were observed between WT and F238A simulations.Structure 21, 1307–1316, August 6, 2013Because the specific subsite for
binding chloroform intrasubunit is not
known from crystallographic structures,
we tested three different subsites. One
location was found close to Y254 and
T255 in M3 as well as I201 and S205 in
M1 (Figures 3D and 3E), which is identical
to the binding site identified for desflur-
ane. A second location involves I202
(M1), Y254 (M3), and N307 (M4), similar
to the previously reported intrasubunit
binding location for propofol (Nury et al.,
2011). Finally, a third subsite involves
V242, F238/A238, N239 (M2), and Y263
(M3). The latter is closer to the linking tun-
nel between intra- and intersubunit cav-
ities and less exposed to the hydropho-
bic membrane region. Despite the small
size and high mobility (rmsf values up to
2.83 A˚) of chloroform, it stayed completely
within these pockets during a 20 ns unre-
strained simulation. Chloroform assumes
three to four different orientations that
convert rapidly and effectively behave as
a single pose.
Intersubunit Binding Conformations
The intersubunit site is delimited by the
M1, M2, M20, and M30 helices (with prime
notation indicating the next subunit; Fig-ure 4). We started our initial simulations with different poses for
desflurane and chloroform. The locations of these ranged from
deep into the TM domain close to the 140 site to poses at
the extracellular (EC)-TM interface of the inte-subunit cavity.
For WT GLIC and F238A, we investigated a binding site forª2013 Elsevier Ltd All rights reserved 1311
Figure 5. Free Energy of Intra- versus Intersubunit Binding
Calculated affinities for GLICWT (black) and F238A (orange) for desflurane and
chloroform in both cavities (Table S2). SE estimates for the free energy
calculation (see Supplemental Experimental Procedures) are indicated; **p <
0.01. Both ligands preferred intrasubunit binding in WT GLIC, but shift to pri-
marily intersubunit binding in F238A. This correlates well with the functional
results in Figure 1 and appears to suggest the intrasubunit binding site is
primarily inhibitory while the intersubunit site is potentiating.
See also Figure S3.
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Ion Channel Modulationdesflurane close to the EC-TM interface (between N200 M1 and
E243 M20), similar to the site proposed for enflurane in GLIC
(Chen et al., 2010). This part of the cavity is water-filled and
made up by polar and charged residues N200, E243, K244,
Y203, and S196 (Figure 2; Table S1). However, the binding free
energies at this site turned out to be significantly higher than
those at the intersubunit subsite close to the 140 site. Further-
more, we expected structural changes caused by the 140 muta-
tion to beminimal at this site and not cause significant changes in
anesthetic binding. Therefore, we mainly investigated the bind-
ing poses in proximity of the 140 site, close to the linking tunnel
between the intra- and intersubunit site (Figures 4B and 4F).
This is the only site where changes were large enough to poten-
tially explain the inversion of the anesthetic effect.
The binding site was defined byM2A238, I243;M1 I201, P204,
I208; M20 R239, I240, I236; M30 263 and lined by N200 and E243.
The rmsf of desflurane bound to WT GLIC was 1.86 A˚ and for the
F238A mutant 1.99 A˚. Furthermore, the two intersubunit confor-
mations of desflurane in WT GLIC occupied the same pocket
with two kinetically distinct orientations that only rarely intercon-
verted, while the MD trajectories of the poses in the F238A
mutant showed fast interchange between several conforma-
tions. Desflurane binding in WT GLIC is located more toward
the EC domain, with a mass center roughly at the level of I240.
There is no overlap with the corresponding binding locations of
desflurane in the F238A mutant, where the site is roughly at the
height of I236. This difference was mainly explained by the steric
restriction caused by the F238 phenyl ring in WT GLIC (cf. Fig-
ures 4C and 4G), which also caused desflurane to bind closer
to N200 and E243 in WT GLIC, where there is a water-filled polar
cavity at the EC-TM interface. Consequently, the ether group of
desflurane is not able to form polar interactions with N239 and
Y263 or hydrophobic interactions with I236 and Y263 further
down in the cavity. In contrast, desflurane bound to GLIC
F238A resulted in just a single cluster representing one binding
pose, where the ligand has characteristic polar interactions1312 Structure 21, 1307–1316, August 6, 2013 ª2013 Elsevier Ltd Alwith M20 N239 and M30 Y263 and hydrophobic interactions
with M30 263; M20 I236, and M2 A238.
For chloroform in the intersubunit cavity, we identified a single
site in WT GLIC with four slightly different conformations. As for
desflurane, chloroform in the WT structure did not penetrate
deeper than the level of I240 (160) in M20, which is significantly
above the 140 site. Three of the conformations identified were
close to this 160 site where they interact with N239 of M20 (150),
and the last conformation close to N200 and E243 (similar to
the desflurane binding in WT; Figure 4D). For chloroform too,
there was a marked change of binding properties with the muta-
tion. Chloroform binding to F238A GLIC had two kinetically
distinct poses; the first is below the 140 site close to I236 (M20),
A238 (M2) and the aromatic ring of Y263 (M30), while the second
pose is one helix turn further up at 160 (I240 in M20), forming polar
contacts to N239 and Y263.
Binding Free Energies
The free energy of binding in each site was derived fromMD sim-
ulations where ligands were restrained in each kinetically distinct
orientation and interactions gradually decoupled (Wang et al.,
2006). The free energy of binding for desflurane in the GLIC
WT intrasubunit cavity was 21.8 ± 0.3 kJ/mol compared
to 19.7 ± 0.4 kJ/mol for F238A (Figure 5). Importantly, these
SE estimates only refer to the ligand sampling, not the much
slower relaxation of the protein, which means the difference is
likely not significant.
For the intrasubunit binding of chloroform, we calculated free
energies in three different pockets. For the deeply buried pocket
at the 140 site close to V242, N239, and Y263, we retrieved a
binding free energy of 3.9 ± 0.4 kJ/mol for WT and 4.1 ±
0.4 kJ/mol for the mutant. The chloroform sites that most closely
resembled the propofol binding sites had binding free energies
of 14.6 ± 0.3 kJ/mol for WT and 13.9 ± 0.4 kJ/mol for
F238A. The intrasubunit chloroform site showing the strongest
binding resulted in free energies of 18.6 ± 0.4 kJ/mol for WT
and 15.5 ± 0.1 kJ/mol for F238A, which is closer to the binding
affinity of desflurane. This reduction in affinity was not coupled to
any change of pose, and further analysis indicated it is rather due
to increased water penetration into the intrasubunit site, which
as discussed previously by Howard and colleagues (Howard
et al., 2011a) is a result of the increased volume of the intersubu-
nit site in GLIC F238A (Table S1).
For binding between subunits, we first considered the higher-
level site located closer to the EC domain. For desflurane bind-
ing in WT GLIC, the binding energy in this site was only 9.5 ±
0.4 kJ/mol, which was the worst of all scanned sites. Because
this location is also relatively far from the 140 site, we did not
expect large changes from the F238A mutation and decided
not to pursue this site further. To evaluate binding in the lower-
level cavity (closer to 140), the overall free energy of binding
was obtained from occupancy-weighted averaging of the free
energies of the multiple kinetically distinct poses. At the intersu-
bunit 140 site, the total free energy of desflurane binding
was 14.4 ± 0.6 kJ/mol for WT GLIC and 23.2 ± 0.5 kJ/mol
for the F238A mutant. Similarly, for chloroform, the free energy
of binding in the intersubunit site was 16.2 ± 0.6 kJ/mol
and 24.8 ± 0.3 kJ/mol for WT and F238A, respectively. Some
caution is advised because protein relaxation could affect thesel rights reserved
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to deteriorate in the mutant with relaxation (which would be
required to alter the qualitative result). The shifts in the intersubu-
nit site are close to 10 kJ/mol, and even a relative difference of
5 kJ/mol corresponds to a factor10 in occupancy at room tem-
perature. In other words, this suggests that the intrasubunit site
is heavily favored for desflurane and favored for chloroform inWT
GLIC, whereas the F238A mutation clearly shifts the most favor-
able location to the intersubunit site for both ligands (Table S2).
To test cooperativity between the two binding sites in F238A,
we also calculated the free energies when desflurane was
present in both binding sites. For the intrasubunit binding of des-
flurane, where desflurane was also present in the intersubunit,
we obtain 20.9 ± 0.8 kJ/mol compared to 19.7 ± 0.4 kJ/mol
without the extra ligand. The intersubunit site binding of
desflurane with desflurane also present in the intrasubunit site
was 23.9 ± 0.3 compared to 23.2 ± 0.5 kJ/mol for the refer-
ence case. Thus, it appears prior binding in one site has little
influence on the affinity in the other site.
DISCUSSION
Wepreviously showed that GLIC exhibits bimodal modulation by
n-alcohols, being potentiated by short-chain alcohols (methanol,
ethanol) but inhibited by long-chain alcohols (propanol and
larger; Howard et al., 2011a). Substituting alanine for phenylala-
nine at the 140 position in the GLIC M2 helix (F238A) dramatically
altered alcohol modulation, enhancing potentiation by short-
chain alcohols and converting alcohols as large as n-hexanol
from inhibitors into potentiators (Howard et al., 2011a). The pre-
sent work now shows that the F238A mutation also completely
reverses the action of several volatile anesthetics, converting
them from inhibitors into potentiators. Thus, consistent with
past evidence that alcohols and anesthetics act via shared bind-
ing sites on pLGICs (Mascia et al., 2000), long-chain n-alcohols
and anesthetics modulate GLIC in a parallel fashion, involving
the F238 residue. Our free energy calculations on docked des-
flurane and chloroform suggest this is coupled to differential
binding, with the intrasubunit site being preferred in WT GLIC,
while the intersubunit site is enlarged and favored in the F238A
mutant. We propose a model with two sites of action with
opposing effects. The functional effect on the channel is a result
of competitive binding between these two sites, although there
does not appear to be any cooperativity effects between the
sites. This could explain the complex dose-response curve
where binding to a single site initially causes the effect, but
when this is saturated and the second site is increasingly occu-
pied, the effect is suddenly reversed. In contrast, a single site-
model where occupancy triggers different modes of action
would likely result in a linear dose-response curve.
Previous structural studies raised the possibility that the occu-
pancy of anesthetics, even at saturating concentrations, might
be low in GLIC TM cavities, given the high B-factors associated
with the bound drugs (Nury et al., 2011). In contrast, our simula-
tions are consistent with the explanation that high B-factors arise
from high mobility and conformational entropy of the anesthetic
molecule within its binding site: in many cases, the modulator
was seen to flip its orientation 180 several times in the course
of a single simulation. We were able to observe this mobility inStructure 21, 1307all five semisymmetric cavities docked in each simulation, but
with no evident cooperativity. This high mobility may arise from
a lack of strong electrostatic interactions defining a particular
pose in the binding cavity.
Assuming high overall occupancy, we infer that even relatively
disfavored binding sites contribute to the net modulation, partic-
ularly under the high (low millimolar) concentrations of anes-
thetics used for functional experiments in this study. This
hypothesis is consistent with previous studies supporting the
existence of multiple simultaneous interaction sites for allosteric
modulators on pLGICs, in some cases with opposing functional
consequences (Borghese et al., 2003; Crawford et al., 2007;
Howard et al., 2011b). Indeed, the low Hill coefficients observed
for anesthetic inhibition of WT GLIC are consistent with multiple
antagonistic sites of action or possibly with negative cooperativ-
ity (Weng et al., 2010).We also noted that, although high concen-
trations of desflurane dramatically potentiated GLIC F238A
currents, moderate concentrations (<3 MAC) had a smaller
absolute effect on the mutant than on WT: 1 MAC desflurane
inhibited WT GLIC by 50%, but did not significantly alter GLIC
F238A. This decreased apparent affinity is consistent with
more closely balanced binding at opposing sites of action in
the mutant, as predicted by our binding free energy calculations.
The intrasubunit cavity used for initial docking in this studywas
the unique site of desflurane binding in a recent crystal structure
of WT GLIC (Nury et al., 2011). Of the three binding poses we
identified for desflurane in WT GLIC, the highest affinity one
was remarkably close to the X-ray co-crystal. Chloroform too
was found to bind in this location, while the propofol site in the
co-crystal is more similar to one of our alternative poses. Given
that WT GLIC exhibits net inhibition by desflurane, this site was
proposed to be an inhibitory site of action (Nury et al., 2011).
Conversely, a nearby cavity at the intersubunit interface was
recently implicated in potentiating actions of n-alcohols on
GLIC (Howard et al., 2011a) as well as GlyRs (Murail et al.,
2011). In this study, we provide quantitativemeasures of the rela-
tive free energies of binding to the intrasubunit (putative inhibi-
tory) and intersubunit (putative potentiating) cavities in GLIC
WT and F238A channels. The F238A mutation made desflurane
binding to the intrasubunit site slightly less favorable, but
enhanced binding to the intersubunit site 2-fold. The net effect
implies there should be an inversion of the occupancy in the
two sites, which correlates well with a switch from inhibition to
potentiation by desflurane.
In the intersubunit cavity, we tested three possible docking
poses at varying levels of penetration into the TM core. For the
F238Amutant, the deepest binding pose—essentially occupying
the cavity left by the substituted F238 side chain—was the most
favorable. However, in the WT protein, this pose was almost
completely occluded; instead, the optimal intersubunit pose
was translated by one helical turn toward the extracellular
medium, near residue L241. This binding pose is supported by
our previous demonstration that small substitutions at residue
241 enhance ethanol potentiation and that labeling of this resi-
due with a small methanethiosulfonate reagent mimics alcohol
potentiation (Howard et al., 2011a). We tested an additional
binding pose even further toward the EC space, but found it to
be a less significant contributor to binding in either WT or mutant
proteins.–1316, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1313
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binds with similar affinity to the intrasubunit and intersubunit cav-
ities of the GLIC F238Amutant. Indeed, as discussed previously,
moderate desflurane concentrations (1 MAC) have no net effect
on GLIC F238A, possibly reflecting a balance of inhibiting and
potentiating actions. Although one cannot directly translate affin-
ity to efficacy, this might be reflected in the free energies where
the difference between the two sites in F238A ismuch smaller for
desflurane (one in four desfluranes would still occupy the inhib-
itory site) than chloroform (one in 50).
However, at high concentrations, desflurane is a strong poten-
tiator of the GLIC F238A mutant. The net functional effect, then,
may arise from a combination of inhibitory binding to the intrasu-
bunit cavity, plus potentiating interactions with the intersubunit
cavity that are of higher absolute efficacy. As the putative inhib-
itory effect of binding in the intrasubunit cavity saturates, binding
to an intersubunit site with a relatively higher efficacy (but for
potentiation rather than inhibition) could yield the strong net
enhancement observed experimentally. This is in agreement
with a multiple-site model for allosteric regulation. In the WT
channel, the low affinity of binding in the intersubunit cavity
may render it a negligible contributor to net modulation, except
at very high concentrations not tolerated in our oocyte assay.
Of course, it is also possible that structural changes brought
by the F238Amutation increase the efficacy of intersubunit bind-
ing relative to WT, such that the increased affinity reflected in our
free energy calculations leads to an even more dramatically
increased potency of potentiation at high concentrations.
In addition to the intrasubunit and intersubunit TM cavities
studied here, previous molecular dynamics studies (Brannigan
et al., 2010; Chen et al., 2010) have implicated anesthetic binding
sites near the channel pore and M2–M3 loop. Although our sim-
ulations provide a simple quantitative basis for our functional
observations, there could be possible contributions from addi-
tional binding sites or possibly competitive effects from pore
blocking (LeBard et al., 2012); some of this might be possible
to test by combining free energy calculations of the two sites
studied here with pore blocking to understand pLGIC modula-
tion, although this might require an extension to the simplified
two-site model. However, given the presumed promiscuity of
anesthetic binding and their evidently highmobility within a given
binding site, we defined the ‘‘intrasubunit’’ and ‘‘intersubunit’’
site for each protein as the most favorable of a variety of tested
poses. Docking of desflurane in the intrasubunit cavity yielded a
binding pose superimposable with that observed in the crystal
structure (Nury et al., 2011). Docking in alternative poses in this
WT cavity yielded less favorable energies. Furthermore, the
intrasubunit binding pose observed for WT GLIC was conserved
in the F238A structure, consistent with the comparable free
energy of intrasubunit binding for the two proteins.
The binding of general anesthetics to GLIC is likely not limited
to the intrasubunit (I202, S205, and T255) and the intersubunit
(N239, Y263, and I236) sites. A binding site close to the TM
domain/EC domain interface reported for halothane and thio-
pental above N200 (Chen et al., 2010) might also be suitable
for polar anesthetics. Despite lower affinity, we too observed
a possible binding pose for desflurane in this location in WT
GLIC, and ethanol modulation of GLIC was also somewhat
affected by alterations to I240, L241, or N245.1314 Structure 21, 1307–1316, August 6, 2013 ª2013 Elsevier Ltd AlPhenylalanine is conserved at the M2 140 position of several
subtypes of nAChRs, which—like GLIC—were previously shown
to exhibit potentiation by short-chain alcohols but inhibition by
anesthetics and long-chain alcohols (Borghese et al., 2003).
Conversely, the equivalent residue is generally smaller and
more polar in channels such as GABAARs and GlyRs, which
exhibit potentiation rather than inhibition by anesthetics and
alcohols. The recently crystallized GluCla has a glutamine in
this position, and the co-crystal with the potentiator ivermectin
shows the large ligand to be placed between subunits (Hibbs
and Gouaux, 2011), overlapping with our highest-affinity site
for anesthetics in GLIC F238A.
The effect of substituting a smaller, more polar residue at the
140 position in GLIC is thus consistent with a role for this position,
and the nearby intersubunit cavity, in differential sensitivity of
pLGICs to allosteric modulators. Previous studies on GlyR and
GABAAR linked several residues belonging to different subunits
to the modulation of anesthetics and alcohols, which supports
functional effects between subunits, in particular the 150 residues
a1S270/b2N265 (15
0 M2) of GABAAR (Mihic et al., 1997) and S267
(150 M2) of GlyR or S260 (150 M2) of GluCl (Cheng et al., 2008).
These sites are very close to the 140 site in the present study
and support a general anesthetic- and alcohol-binding site in
this location, which appears to be confirmed by a recent GLIC
F238A co-crystal with ethanol bound intersubunit (Sauguet
et al., 2013). Similarly, the earlier structure of GLIC in a locally
closed state (Prevost et al., 2012) indicates that the extracellular
part of M2 helix has moved inward, to some extent detached
from M3, and opened a cavity between them. Our intrasub-
unit site is located close to the lower part of this cavity, and it
appears quite reasonable that ligand binding in this site could
stabilize an already closed channel, resulting in the observed
inhibition, while potentiation in GLIC F238A might be caused
by subunits not being able to move inward when ligands are
bound between them.
In addition to the binding interactions studied here, there may
be indirect effects of the F238A mutation on modulation due to
changes in the energetics of gating. As described previously,
the mutation did right-shift the proton concentration depen-
dence, adjusting the 10% activation condition from pH 5.5 to
pH 5.0; however, neighboring mutations that elicited similar
shifts in gating (e.g., A237C, N239C) did not evoke similar
changes in alcohol modulation, suggesting that these effects
were independent (Howard et al., 2011a). It should also be noted
that our structural models are based on the crystallographic,
presumed open (Bocquet et al., 2009; Hilf et al., 2010) or desen-
sitized (Gonzalez-Gutierrez and Grosman, 2010; Parikh et al.,
2011) state of GLIC. The pore radius did not change significantly
during the short timescale of our simulations (Figure S2), which is
not surprising because closing, desensitizing, or opening are
likely much slower transitions. A complete understanding of
the impact of modulator binding in the sites studied here or
elsewhere will require a detailed model of the channel’s opening
and closing transitions, including the relative free energies of
the channel in (future) closed versus open states and the tran-
sition states between them. However, better understanding of
anesthetic binding in the intersubunit site is an important step
toward understanding modulation of ligand-gated channels in
general.l rights reserved
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Experimental Materials
Volatile anesthetics were purchased from Marsam Pharmaceuticals Inc.
(Cherry Hill, NJ); all other chemicals were purchased from Sigma-Aldrich
(St. Louis, MO). Expression plasmids containing GLIC WT and F238A cDNA
in the PMT3 vector were prepared as previously described (Howard et al.,
2011a). The oocytes were prepared from ovarian tissue ofXenopus laevis frogs
for the two-electrode voltage clamp electrophysiology. Procedures involving
frogs were approved by the University of Texas at Austin Institutional Animal
Care and Use Committee. GLIC currents were measured for pH-dependent
GLIC activation as previously described (Howard et al., 2011a; see Supple-
mental Experimental Procedures for additional details).
Volatile anesthetic solutions were adjusted to deliver the reported con-
centration calibrated by gas chromatography, as described previously (Lin
et al., 1992). The adjusted anesthetic volume was added via positive displace-
ment pipette to the appropriate Ringer’s buffer in a scintillation vial with mini-
mal head space, immediately sealed with parafilm and aluminum foil, and
sonicated for R 2 min. The solution was applied by piercing the seal with
the perfusion input needle, minimizing exposure of the solution surface to
atmosphere. To quantify anesthetic modulation, oocytes were treated for
1 min with low-pH Ringer’s buffer; after 5 min washout, the anesthetic solution
was applied in neutral Ringer’s buffer for 1 min, then in low-pH buffer for
1 min; after another 5 min washout, low-pH buffer was again applied alone.
Modulation was calculated as [(RA  < R0,R1 > ) / < R0,R1 > ] 3 100, where
RA represents the channel response in the presence of anesthetic and <
R0,R1 > represents the mean of the pre- and postanesthetic responses. Initial
anesthetic concentrations were chosen as three times MAC, except for
chloroform, for which 1 MAC was used on account of the large degree of
modulation. Values of MAC were derived as previously described (Mihic
et al., 1994).
Statistics
Data are represented as mean ± SEM. Results were analyzed by two-tailed
unpaired t test with significance set at p < 0.05. The desflurane inhibition curve
for WT GLIC was calculated by nonlinear regression fit to the equation M =
100 / (1 + 10 ^ [log(IC50  A)] $ nH)  100, where M is the percentage modula-
tion, A is the molar concentration of desflurane, IC50 is the concentration
producing 50% inhibition, and nH is the Hill coefficient. Nonlinear regression
analysis and all statistical analyses were performed with GraphPad Prism 5
for Mac (GraphPad Software, San Diego, CA).
Molecular Modeling
Protein Data Bank ID code 3EAM (Bocquet et al., 2009) was used for WTGLIC.
Both WT and F238A systems were embedded into a DOPC bilayer, solvated,
and set to a 100 mM concentration of NaCl (Howard et al., 2011a). Both sys-
tems were subject to 20 ns of simulation with position restraints on backbone
atoms, and the mutant relaxed another 200 ns. Initial ligand poses were iden-
tified with AutoDock 4.2 (Morris et al., 1998) and subject to 20 ns unrestrained
simulations with GROMACS (Hess et al., 2008) to get the kinetically distinct
ligand binding poses. A restraining potential was used during free energy cal-
culations (Figure S3). Additional details about docking and parameters are
described in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.str.2013.06.018.
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